Philadelphia, PA, December 9, 2025
Adare Pharma Solutions has announced the closure of its manufacturing facility in Northeast Philadelphia, resulting in the loss of 137 jobs by June 2026. This decision reflects the impact of adverse economic conditions on client demand and the complexities facing local businesses. The company is exploring options for reassignment of affected employees within its other facilities, showcasing its commitment to workforce retention despite operational challenges.
Philadelphia, PA
Adare Pharma Solutions to Close Manufacturing Plant, 137 Jobs Lost
The recent announcement from Adare Pharma Solutions regarding the closure of its manufacturing plant in Northeast Philadelphia has raised concerns and highlighted the challenges facing local businesses. As the company consolidates its operations, the loss of 137 jobs reflects both the adverse economic conditions impacting its clients and the complexities of navigating today’s ever-evolving market landscape.
This closure, scheduled to take place by June 2026, emphasizes the delicate balance between maintaining workforce stability and addressing operational efficiency. Adare Pharma Solutions is investigating pathways to reassign some affected employees to other locations, demonstrating a commitment to workforce retention despite industry pressures.
Details of the Closure
Situated in the Port Richmond area, the Orthodox Street facility has played a crucial role in the company’s operations. The consolidation reflects broader economic realities that many businesses face, where reduced client demand has necessitated such difficult decisions. While the company’s corporate headquarters remains at its Dungan Road facility in Philadelphia, the closure signals a strategic pivot in response to these conditions.
Background Information
In August 2024, Adare Pharma Solutions moved its global headquarters from Lawrenceville, New Jersey, to Philadelphia, supported by nearly $3 million in state funding. This relocation aimed to create 115 new jobs and retain 200 existing positions, demonstrating a proactive approach to growth and community engagement. The company operates two facilities in Philadelphia, enhancing the region’s position in the pharmaceutical landscape.
Industry Context
As a global contract development and manufacturing organization, Adare Pharma Solutions specializes in oral dosage forms for the pharmaceutical industry. Its comprehensive range of services, which includes product development and commercial manufacturing, showcases the innovation and technical expertise present in the local industry. Even amidst this consolidation, the company continues to focus on its strengths in patient-centric solutions and product enhancements.
Impact on the Community
The closure’s immediate impact will be felt by 137 employees in the Northeast Philadelphia community. While the prospects for reassignment are uncertain, the company is making efforts to explore potential opportunities elsewhere within its facilities. The value of supporting local employees during economic transitions cannot be overstated, as retention can significantly affect community resilience.
Future Outlook
Despite the closure of the Orthodox Street facility, Adare Pharma Solutions’ strategy underscores its commitment to Philadelphia, with continued investments in the Dungan Road facility. This focus on maintaining a robust presence in the area reflects the company’s long-term vision for growth and stability, prioritizing both community involvement and operational efficiency.
Conclusion
The decision to close the Orthodox Street plant serves as a case study of the challenges and adaptations businesses face in volatile economic conditions. Adare Pharma Solutions remains dedicated to its Philadelphia operations and is actively seeking ways to navigate this transitional phase while supporting its workforce and maintaining its commitment to innovation in the pharmaceutical sector.
FAQ
What is the reason for the closure of Adare Pharma Solutions’ Philadelphia plant?
The company cited adverse economic conditions affecting its clients as the primary reason for the closure.
How many employees will be affected by the plant closure?
The closure will result in the elimination of 137 jobs.
Will any employees be reassigned to other locations?
Adare Pharma Solutions is exploring opportunities to reassign some affected employees to other company locations.
Is Adare Pharma Solutions closing all its facilities in Philadelphia?
No, the company is maintaining its corporate headquarters and operations at the Dungan Road facility in Philadelphia.
What services does Adare Pharma Solutions provide?
Adare Pharma Solutions is a global contract development and manufacturing organization specializing in oral dosage forms for the pharmaceutical industry, offering services from product development to commercial manufacturing.
Key Features
| Feature | Details |
|---|---|
| Closure Location | Orthodox Street facility, Northeast Philadelphia |
| Number of Jobs Eliminated | 137 |
| Closure Timeline | By June 2026 |
| Reason for Closure | Adverse economic conditions affecting clients |
| Corporate Headquarters | Dungan Road facility, Philadelphia |
| State Support for Relocation | Nearly $3 million in state funding |
| Expected Job Creation from Relocation | 115 new jobs |
| Existing Jobs Retained | 200 |
| Company’s Services | Contract development and manufacturing for oral dosage forms |
Deeper Dive: News & Info About This Topic
HERE Resources
Scranton’s New Legislation Boosts Workforce Development
Author: STAFF HERE PHILADELPHIA WRITER
The PHILADELPHIA STAFF WRITER represents the experienced team at HEREPhiladelphia.com, your go-to source for actionable local news and information in Philadelphia, Philadelphia County, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as Mummers Parade, Philadelphia Flower Show, and Thanksgiving Day Parade. Our coverage extends to key organizations like the Greater Philadelphia Chamber of Commerce and United Way of Greater Philadelphia, plus leading businesses in telecommunications, food services, and healthcare that power the local economy such as Comcast, Aramark, and Children's Hospital of Philadelphia. As part of the broader HERE network, we provide comprehensive, credible insights into Pennsylvania's dynamic landscape.
